COMMUNIQUÉS West-GlobeNewswire

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

13/02/2025 - 22:34

MOUNTAIN VIEW, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced that it intends to offer and sell, in an underwritten public offering, $65 million of shares of its common stock. [...]

Outset Medical Announces Resolution of Warning Letter

13/02/2025 - 22:35

SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]

Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

13/02/2025 - 23:00

TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free [...]

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

12/02/2025 - 14:03

The Company will Host a Conference Call and Webcast on February 27, 2025, at 8:30 AM ET CORAL GABLES, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a [...]

MAPS Announces Search for New Executive Director as it Doubles Down on Advocacy and Movement Building

12/02/2025 - 14:30

MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion, and major donor [...]

Bluejay Therapeutics Appoints Mary Cromwell as Senior Vice President and Head of Technical Operations

12/02/2025 - 14:30

REDWOOD CITY, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics , a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver [...]

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

12/02/2025 - 14:50

Rebranding Invizyne Technologies, Inc to eXoZymes Inc. Changing NASDAQ ticker from IZTC to EXOZ Introducing but not trademarking “exozymes” as a new scientific nomenclature Monrovia, California, Feb. 12, 2025 (GLOBE [...]

New York Blood Center Enterprises Researchers Identify New Immune Response Mechanisms in Sickle Cell Disease

12/02/2025 - 15:00

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- New York City Blood Center Enterprises (“NYBCe”) today announced that their researchers have uncovered a critical mechanism that could potentially transform treatment [...]

Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

12/02/2025 - 15:00

New Patent expands patent estate covering Adial’s unique molecular genetic approach to diagnosing and potentially treating alcohol and drug dependence GLEN ALLEN, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Adial [...]

ZymoChem Achieves Commercial-Scale Production of Key Biopolymer Ingredient For BAYSE BioSAP

12/02/2025 - 15:00

Biomanufacturing Leader Scales Up Technology to Drive Sustainability in Chemicals Industry SAN LEANDRO, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZymoChem , the biotech company creating sustainable materials for [...]

Pédalons pour la cause : la Jack Ride mobilise le pays pour la santé mentale des jeunes

12/02/2025 - 15:00

Rejoignez les milliers de Canadien.ne.s qui se mobilisent pour offrir espoir et soutien à la jeunesse LÉGENDE : Des centaines de participant.e.s qui unissent leurs efforts lors de la Jack Ride pour financer des [...]

Pedal for Progress with Jack Ride: Canadians Ride for Youth Mental Health

12/02/2025 - 15:00

Join tens of thousands of Jack.org supporters to raise hope and funds together CAPTION: Hundreds come together for Jack Ride to support programs equipping youth with vital mental health education TORONTO, Feb. 12, 2025 [...]

Board member Roland Norberg requests to resign from the Board

12/02/2025 - 16:00

Aino Health AB's board member Roland Norberg has today, 12 February 2025, requested to resign from the company's board. The reason for the resignation is that the company that nominated Roland Norberg, Norberg & [...]

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

12/02/2025 - 16:43

Late-breaking oral presentation features echocardiographic data analysis showing favorable impact of AVIM therapy on MODERATO II study patients with diastolic dysfunction, a key component in the development of heart [...]

Tanke Biosciences Corp Announces Appointment of Vincent Renz as Chief Executive Officer and Member of the Board of Directors

12/02/2025 - 17:00

Las Vegas, NV, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that Vincent Renz has been appointed Chief Executive Officer and will join the Board of Directors, [...]

Genmab Publishes 2024 Annual Report

12/02/2025 - 17:01

Company Announcement COPENHAGEN, Denmark; February 12, 2025 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2024. Below is a summary of business progress in 2024, financial [...]

Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025

12/02/2025 - 17:02

ALK ( ALKB:DC / OMX: ALK B / AKBLF ) will publish its annual report for 2024 in the morning on Wednesday, 19 February 2025. Later on the same day, the company will host a presentation for investors and analysts at 1:30 [...]

Legend Senior Living® Expands with New Residence in King of Prussia

12/02/2025 - 17:19

PHILADELPHIA, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior living provider headquartered in Wichita, KS, is partnering in the new ownership and will operate Anthology Living in King of [...]

FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)

12/02/2025 - 17:45

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and safety as the [...]